0001209191-15-070584.txt : 20150914 0001209191-15-070584.hdr.sgml : 20150914 20150914182617 ACCESSION NUMBER: 0001209191-15-070584 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150910 FILED AS OF DATE: 20150914 DATE AS OF CHANGE: 20150914 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arcadia Biosciences, Inc. CENTRAL INDEX KEY: 0001469443 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] IRS NUMBER: 810571538 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 202 COUSTEAU PLACE STREET 2: SUITE 200 CITY: DAVIS STATE: X1 ZIP: 95618 BUSINESS PHONE: 602-429-0476 MAIL ADDRESS: STREET 1: 4222 E. THOMAS RD STREET 2: SUITE 245 CITY: PHOENIX STATE: X1 ZIP: 85018 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Emlay Don CENTRAL INDEX KEY: 0001640702 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37383 FILM NUMBER: 151106437 MAIL ADDRESS: STREET 1: ARCADIA BIOSCIENCES, INC. STREET 2: 202 COUSTEAU PLACE, SUITE 105 CITY: DAVIS STATE: CA ZIP: 95618 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-09-10 0 0001469443 Arcadia Biosciences, Inc. RKDA 0001640702 Emlay Don C/O ARCADIA BIOSCIENCES, INC. 202 COUSTEAU PLACE, SUITE 105 DAVIS CA 95618 0 1 0 0 VP Regulatory and Compliance Common Stock 2015-09-10 4 M 0 1588 0.44 A 12838 D Common Stock 2015-09-10 4 S 0 548 5.2708 D 12290 D Common Stock 2015-09-11 4 M 0 6397 0.44 A 18687 D Common Stock 2015-09-11 4 S 0 2284 4.9181 D 16403 D Common Stock 2015-09-14 4 M 0 2015 0.44 A 18418 D Common Stock 2015-09-14 4 S 0 689 4.8061 D 17729 D Employee Stock Option (right to buy) 0.44 2015-09-10 4 M 0 1588 0.00 D 2015-12-31 Common Stock 1588 8412 D Employee Stock Option (right to buy) 0.44 2015-09-11 4 M 0 6397 0.00 D 2015-12-31 Common Stock 6397 2015 D Employee Stock Option (right to buy) 0.44 2015-09-14 4 M 0 2015 0.00 D 2015-12-31 Common Stock 2015 0 D The security transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan (the "Plan"), adopted by the Reporting Person effective June 12, 2015. Pursuant to the Plan and in compliance with the Issuer's IPO Lock-up Agreements with Credit Suisse Securities (USA) ("CSSU"), the Reporting Person paid the exercise price and CSSU sold shares only to satisfy the tax liability and costs. The balance of the shares will be held until the expiration of the IPO Lock-up Agreements. This transaction was executed in multiple trades at prices ranging from $5.10 to $5.56. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $4.79 to $5.11. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $4.780 to $4.850. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The option is fully exercisable as of the date hereof. Don Emlay, by Attorney in Fact, Wendy S. Neal 2015-09-14